Hemopoetic organs damage syndrome in patients with chronic viral hepatitis

Georgian Medical News
|April 19, 2005
PubMed

Insights

Hematological disorders are common in chronic hepatitis C, even outside the liver. The severity of these blood cell abnormalities does not always correlate with liver damage or disease activity.

Area of Science:

  • Hepatology
  • Hematology
  • Virology

Background:

  • Chronic hepatitis C (HCV) can lead to severe complications like liver cirrhosis and hepatocellular carcinoma.
  • Emerging evidence suggests HCV may persist and replicate in organs beyond the liver.
  • Understanding extrahepatic manifestations is crucial for comprehensive patient management.

Purpose of the Study:

  • To investigate hematological disorders in patients with chronic hepatitis C and co-infection with hepatitis B (HBV).
  • To explore the correlation between chronic hepatitis activity, cirrhosis stage, and the extent of hematological abnormalities.
  • To assess the degree of extrahepatic hematological disorders in relation to liver damage.

Main Methods:

  • Studied 77 patients with HCV-induced cirrhosis and 36 patients with chronic hepatitis C or C+B hepatitis.
  • Erythrocyte morphology analyzed via light microscopy.
  • Erythrocyte osmotic resistance assessed using the Ianovski method (Ribiera modification).
  • Platelet adhesion and aggregation evaluated using Rite's method.
  • Absolute platelet counts determined by phase-contrast microscopy.

Main Results:

  • Hematological disorders were observed in patients with chronic hepatitis C and cirrhosis.
  • No absolute correlation was found between the activity of chronic hepatitis C and the degree of hematological disorders.
  • Extrahepatic hematological disorders were often more pronounced than the extent of liver damage.

Conclusions:

  • Hematological abnormalities are a significant feature of chronic hepatitis C, extending beyond hepatic involvement.
  • The degree of liver damage does not consistently predict the severity of associated blood disorders.
  • Further research into the mechanisms and clinical implications of these extrahepatic manifestations is warranted.

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...